Narrative Medicine for Parents of Children With Urogenital Conditions
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether guided journaling, known as the Narrative Medicine Journaling Intervention, can reduce stress and anxiety in parents of children with urogenital conditions, such as differences in sex development or hypospadias. The researchers aim to determine if writing about emotions helps parents feel less anxious and gather insights on group writing programs for future support. Participants will write in a journal using prompts and share their experiences in a follow-up interview. This trial suits parents whose child receives care for a urogenital condition at Boston Children's Hospital and who are open to writing or dictating journal entries over several weeks. As an unphased trial, it offers a unique opportunity for parents to explore new ways to manage stress and anxiety through innovative journaling techniques.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on journaling and interviews, so it's unlikely that your medications would be affected.
What prior data suggests that this journaling intervention is safe for parents?
Research has shown that activities like journaling, part of narrative medicine, are generally safe and easy for people to do. One study found that storytelling in healthcare can improve well-being and aid in medication adherence. Reports of negative effects from journaling as a treatment are absent. Instead, it appears to enhance feelings of connection and reduce isolation. This suggests that the journaling activity in this trial is likely safe for participants, with minimal risk of negative effects.12345
Why are researchers excited about this trial?
Researchers are excited about the Narrative Medicine Journaling Intervention because it offers a unique approach to helping parents of children with urogenital conditions manage their anxiety. Unlike traditional treatments that might focus on medication or therapy for anxiety, this intervention uses guided journaling to empower parents to process their experiences and emotions. This method is designed to provide emotional relief by encouraging self-reflection and personal storytelling. By potentially reducing anxiety through a non-invasive, self-directed activity, this intervention could offer a valuable, low-risk complementary option to existing anxiety treatments.
What evidence suggests that this journaling intervention might be an effective treatment for reducing anxiety in parents of children with urogenital conditions?
Research has shown that parents of children with urogenital conditions, such as differences in sex development and hypospadias, often experience high levels of anxiety. This anxiety can be as intense as that experienced by parents of critically ill infants. In this trial, all participants will engage in a Narrative Medicine Journaling Intervention, which involves guided journaling to help reduce stress. Studies on similar writing activities have shown promise in lowering anxiety and improving mental health. Writing about their experiences and feelings may provide parents with relief from stress and anxiety.678910
Are You a Good Fit for This Trial?
This trial is for parents of children with urogenital conditions like differences of sex development and hypospadias. It's designed to see if writing in a journal can help them feel less stressed or anxious.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a physical journal with 5 writing prompts and complete 5 journal entries over several weeks
Follow-up
Participants complete a follow-up anxiety questionnaire and participate in a 45-minute interview to discuss the journaling intervention
What Are the Treatments Tested in This Trial?
Interventions
- Narrative Medicine Journaling Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sarah Schlegel
Lead Sponsor
Harvard Catalyst Pilot Grant
Collaborator